TNFSF13B and B-cell chronic lymphocytic leukemia: The fraction of viable CLL cells from the CD40L/APRIL/BAFF co-culture at day R8 (13 days after the primary co-culture) was significantly higher compared to the fraction of viable CLL cells from the control fibroblast co-culture (70% vs 1%) (Fig. 2d).